CANCER CELLS PRESENT

CANCER CELLS PRESENT was reported 43 times

These drug classes are most commonly taken by patients reporting CANCER CELLS PRESENT:

# Drug Count
0 Janus Kinase Inhibitor [EPC] 8
1 Kinase Inhibitor [EPC] 3
2 Programmed Death Ligand-1 Blocker [EPC] 3
3 5-alpha Reductase Inhibitor [EPC] 2
4 BCL-2 Inhibitor [EPC] 2
5 Benzodiazepine [EPC] 2
6 Expectorant [EPC] 2
7 Nonsteroidal Anti-inflammatory Drug [EPC] 2
8 Osmotic Laxative [EPC] 2
9 Thalidomide Analog [EPC] 2
10 Vitamin C [EPC] 2
11 Aldosterone Antagonist [EPC] 1
12 Aminosalicylate [EPC] 1
13 Androgen [EPC] 1
14 Angiotensin 2 Receptor Blocker [EPC] 1
15 Antiparasitic [EPC] 1
16 Arteriolar Vasodilator [EPC] 1
17 Azole Antifungal [EPC] 1
18 Bile Acid [EPC] 1
19 Calcium [EPC] 1
20 Catecholamine [EPC] 1
21 Chloride Channel Activator [EPC] 1
22 Dihydropyridine Calcium Channel Blocker [EPC] 1
23 Estrogen [EPC] 1
24 GLP-1 Receptor Agonist [EPC] 1
25 GLP-2 Analog [EPC] 1
26 Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] 1
27 HER2/neu Receptor Antagonist [EPC] 1
28 Histamine-1 Receptor Antagonist [EPC] 1
29 Histamine-2 Receptor Antagonist [EPC] 1
30 Human Immunoglobulin G [EPC] 1
31 Microtubule Inhibitor [EPC] 1
32 Nucleoside Metabolic Inhibitor [EPC] 1
33 P2Y12 Platelet Inhibitor [EPC] 1
34 Pediculicide [EPC] 1
35 Platelet Aggregation Inhibitor [EPC] 1
36 Platinum-based Drug [EPC] 1
37 Potassium Salt [EPC] 1
38 Progesterone [EPC] 1
39 Prostaglandin E1 Analog [EPC] 1
40 Proton Pump Inhibitor [EPC] 1
41 Purine Antimetabolite [EPC] 1
42 Radioligand Therapeutic Agent [EPC] 1
43 Tetracycline-class Drug [EPC] 1
44 Thiazide Diuretic [EPC] 1
45 Tumor Necrosis Factor Blocker [EPC] 1
46 Xanthine Oxidase Inhibitor [EPC] 1
47 alpha-Adrenergic Agonist [EPC] 1
48 beta-Adrenergic Agonist [EPC] 1